Table 1:
Results and statistical analysis of the study.
| Group A (Microneedling monotherapy) |
Group B (Microneedling with autologous PRP) |
P-value (P-value <0.05 considered statistically significant) |
|
|---|---|---|---|
| MSS Score (Mean±SD) at the end of 20 weeks. | 9.60±1.724 | 6.87±0.834 | 0.01 (t-test applied) |
| Patient satisfaction score (Mean±SD) at the end of 20 weeks. | 2.60 ±0.507 | 4.13 ±0.258 | 0.02 (t-test applied) |
| Global improvement scale (Mean±SD) at the end of 20 weeks. | 1.80±0.414 | 3.07 ± 0.258 | 0.019 (t-test applied) |
| Major side effects | nil | nil | - |
| Side effects documented | Pain: severe intensity=0 moderate intensity=1 (6.6%) participant. Mild intensity=10 (66%) No pain=4 (26.6%) Post-inflammatory hyperpigmentation-n=0 Mild burning sensations: n=2 (13.3%) Mild erythema: n=13 (86.6%) |
Pain: severe intensity=0 moderate intensity=0. Mild intensity=12 (80%) No pain=3 (80%) Post-inflammatory hyperpigmentation n=1 (3.33%) Mild burning sensations: n=3 (20%) Mild erythema: n=14 (93.3%) |
0.383 |
MSS: Manchester scar scale, SD: Standard deviation, PRP: Platelet-rich plasma